People with advanced cardiovascular-kidney-metabolic (CKM) syndrome face higher cancer risk. The study analysed 1.4 million Japanese patients over 3.4 years for cancer incidence. Cancer risk rises progressively from CKM stage 1 to stage 4, peaking at 30%.